LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study.

Cai, Huan / Yang, Lisha / Lu, Yingfeng / Zhang, Shanyan / Ye, Chanyuan / Zhang, Xiaoli / Yu, Guodong / Gu, Jueqing / Lian, Jiangshan / Hao, Shaorui / Hu, Jianhua / Zhang, Yimin / Jin, Ciliang / Sheng, Jifang / Yang, Yida / Jia, Hongyu

BMC infectious diseases

2021  Volume 21, Issue 1, Page(s) 147

Abstract: ... to characterize the clinical features and outcomes of imported COVID-19 patients with high body mass index (BMI ... cohort study, 455 imported COVID-19 patients were admitted and discharged in Zhejiang province by February 28 ... hospitalization duration and anti-virus course. Thus, high BMI is a risk factor for the progression and prognosis ...

Abstract Background: Coronavirus disease 2019(COVID-19) has spread worldwide. The present study aimed to characterize the clinical features and outcomes of imported COVID-19 patients with high body mass index (BMI) and the independent association of BMI with disease severity.
Methods: In this retrospective cohort study, 455 imported COVID-19 patients were admitted and discharged in Zhejiang province by February 28, 2020. Epidemiological, demographic, clinical, laboratory, radiological, treatment, and outcome data were collected, analyzed and compared between patients with BMI ≥ 24and < 24.
Results: A total of 268 patients had BMI < 24, and 187 patients had BMI ≥ 24. Those with high BMI were mostly men, had a smoking history, fever, cough, and sputum than those with BMI < 24. A large number of patients with BMI ≥ 24 were diagnosed as severe/critical types. Some biochemical indicators were significantly elevated in patients with BMI ≥ 24. Also, acute liver injury was the most common complication in these patients. The median days from illness onset to severe acute respiratory syndrome coronavirus 2 detection, duration of hospitalization, and days from illness onset to discharge were significantly longer in patients with BMI ≥ 24 than those with BMI < 24. High BMI, exposure to Wuhan, any coexisting medical condition, high temperature, C-reactive protein (CRP), and increased lactate dehydrogenase (LDH) were independent risk factors for severe/critical COVID-19. After adjusting for age, sex and above factors, BMI was still independently associated with progression to severe/critical illness (P = 0.0040). Hemoglobin, alanine aminotransferase (ALT), CRP, and serum creatinine (Scr) were independent risk factors associated with high BMI.
Conclusions: Contrasted with the imported COVID-19 patients with BMI < 24, high proportion of COVID-19 patients with BMI ≥ 24 in our study, especially those with elevated CRP and LDH, developed to severe type, with longer hospitalization duration and anti-virus course. Thus, high BMI is a risk factor for the progression and prognosis of imported COVID-19.
MeSH term(s) Adult ; Body Mass Index ; COVID-19/epidemiology ; COVID-19/etiology ; China/epidemiology ; Cohort Studies ; Disease Progression ; Female ; Hospitalization ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Risk Factors ; SARS-CoV-2
Language English
Publishing date 2021-02-05
Publishing country England
Document type Journal Article ; Multicenter Study
ZDB-ID 2041550-3
ISSN 1471-2334 ; 1471-2334
ISSN (online) 1471-2334
ISSN 1471-2334
DOI 10.1186/s12879-021-05818-0
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top